Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: Agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells

被引:38
|
作者
Watt, Heather L. [2 ]
Kharmate, Geetanjali D. [1 ]
Kumar, Ujendra [1 ]
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Div Pharmacol & Toxicol, Vancouver, BC V6T 1W5, Canada
[2] McGill Univ, Royal Victoria Hosp, Dept Expt Med, Fac Med, Montreal, PQ H3A 1A1, Canada
关键词
Somatostatin; Somatostatin receptors; Epidermal growth factor; Epidermal growth factor receptors; Dimerization; Extracellular signal-regulated kinase; HORMONE-RELEASING HORMONE; ESTROGEN-RECEPTOR; PROGNOSTIC VALUE; ERBB RECEPTORS; MESSENGER-RNA; EGF RECEPTOR; SUBTYPE; FACTOR-I; EXPRESSION; PROTEIN;
D O I
10.1016/j.cellsig.2008.11.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of somatostatin (SST) and epidermal growth factor (EGF) in breast cancer is undisputed: however, the molecular mechanisms underlying their antiproliferative or proliferative effects are not well understood. We initially confirmed that breast turnout tissues express all five somatostatin receptors (SSTR1-5) and four epidermal growth factor receptors (ErbB1-4). Subsequently, to gain insight into the function of SSTRs and ErbBs in oestrogen receptor (ER)-positive (MCF-7) or ER alpha-negative (MDA-MB-231) breast cancer cells, we defined SSTR1, SSTR5 and ErbB1 mRNA and protein expression in these two tumour cell lines. Consistent with previous studies showing SSTR1/SSTR5 heterodimerization and having seen cell-specific and ligand-selective alterations in receptor expression, we next elucidated whether SSTR1 and SSTR5 functionally interactwith ErbB1 using pbFRET analysis. We subsequently determined the effects of SST and EGF either alone, or in combination, on selected downstream signalling molecules such as erk1/2, p38 and JNK. Here, we showed that both SST and EGF influenced erk1/2 phosphorylation and that SST modulated the effects of EGF in a cell-specific manner. We also demonstrated agonist-, time and cell-dependent regulation of p38 phosphorylation. We further investigated modulation of Grb2, SOS, Shc, SH-PTP1 and SH-PTP2. ErbB1 adaptor proteins known to play a role in MAPK activation, Shc, Grb2 and SOS, changed in an agonist- and cell-specific manner whereas, SH-PTP1 and SH-PTP2, adaptor proteins reported to interact with SSTRs, translocated from the cytosol to membrane in a cell-specific manner following SST and/or EGF treatment. Although several previous studies have shown crosstalk between RTKs and GPCRs, there are no reports describing SSTR (GPCR) modulation of ErbBs (RTK) in breast cancer. To the best of our knowledge, this is the first report describing crosstalk/interactions between SSTRs and ErbBs. (c) 2008 Published by Elsevier Inc.
引用
收藏
页码:428 / 439
页数:12
相关论文
共 50 条
  • [21] Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells
    Asanuma, H
    Torigoe, T
    Kamiguchi, K
    Hirohashi, Y
    Ohmura, T
    Hirata, K
    Sato, M
    Sato, N
    CANCER RESEARCH, 2005, 65 (23) : 11018 - 11025
  • [22] Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells
    Li, Ping
    Veldwijk, Marlon R.
    Zhang, Qing
    Li, Zhao-bin
    Xu, Wen-cai
    Fu, Shen
    BMC CANCER, 2013, 13
  • [23] Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells
    Ping Li
    Marlon R Veldwijk
    Qing Zhang
    Zhao-bin Li
    Wen-cai Xu
    Shen Fu
    BMC Cancer, 13
  • [24] ADP-ribosylation Factor 1 Controls the Activation of the Phosphatidylinositol 3-Kinase Pathway to Regulate Epidermal Growth Factor-dependent Growth and Migration of Breast Cancer Cells
    Boulay, Pierre-Luc
    Cotton, Mathieu
    Melancon, Paul
    Claing, Audrey
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (52) : 36425 - 36434
  • [25] Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs
    Manupati, Kanakaraju
    Dhoke, Neha R.
    Debnath, Tanusree
    Yeeravalli, Ragini
    Guguloth, Kalpana
    Saeidpour, Shahrzad
    Chandra, De Utpal
    Debnath, Sudhan
    Das, Amitava
    FEBS JOURNAL, 2017, 284 (12) : 1830 - 1854
  • [26] Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells
    Huo, Longfei
    Li, Chia-Wei
    Huang, Tzu-Hsuan
    Lam, Yung Carmen
    Xia, Weiya
    Tu, Chun
    Chang, Wei-Chao
    Hsu, Jennifer L.
    Lee, Dung-Fang
    Nie, Lei
    Yamaguchi, Hirohito
    Wang, Yan
    Lang, Jingyu
    Li, Long-Yuan
    Chen, Chung-Hsuan
    Mishra, Lopa
    Hung, Mien-Chie
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2014, 6 (06): : 649 - 663
  • [27] Cyclopamine increases the radiosensitivity of human pancreatic cancer cells by regulating the DNA repair signal pathway through an epidermal growth factor receptor-dependent pathway
    Wu, Xiao-Yang
    Che, Jun
    Sun, Ke-Kang
    Shen, Xiao-Jun
    Yang, Dong
    Zhong, Ning
    Zhao, Hua
    MOLECULAR MEDICINE REPORTS, 2013, 8 (04) : 979 - 983
  • [28] Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells
    Thyagarajan, Anita
    Kadam, Sayali M.
    Liu, Langni
    Kelly, Lisa E.
    Rapp, Christine M.
    Chen, Yanfang
    Sahu, Ravi P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (01):
  • [29] Understanding the Interplay between Human Epidermal Growth Factor Receptor 2 and Neuraminidase 1 on the Regulation of Fatty Acid Binding Protein 5 in Breast Cancer Cells
    McCullough, Ian
    Thulasiraman, Padmamalini
    FASEB JOURNAL, 2020, 34
  • [30] Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB Ligands and remain dependent on the ErbB receptor network
    Ritter, Christoph A.
    Perez-Torres, Marianela
    Rinehart, Cammie
    Guix, Marta
    Dugger, Teresa
    Engelman, Jeffrey A.
    Arteaga, Carlos L.
    CLINICAL CANCER RESEARCH, 2007, 13 (16) : 4909 - 4919